Caspase-1 Protein

Caspase-1 Protein

<div class="infobox infobox-protein">

| Property | Value |
|----------|-------|
| Protein Name | Caspase-1 |
| Gene | CASP1 |
| UniProt ID | P29466 |
| Molecular Weight | ~45 kDa (active enzyme) |
| Subcellular Localization | Cytoplasm, inflammasome complexes |
| Protein Family | Caspase family (inflammatory caspases) |
| Tissue Expression | Primarily immune cells; low in healthy brain |

</div>

Overview

Caspase-1 is an inflammatory caspase encoded by the [CASP1](/genes/casp1) gene that plays central roles in the innate immune response and inflammatory cell death (pyroptosis)[@martin2019]. It is synthesized as an inactive zymogen (pro-caspase-1) that is activated by assembly into inflammasome complexes in response to pathogen-associated molecular patterns (PAMPs) and damage-associated molecular patterns (DAMPs).

Once activated, caspase-1 performs two critical functions: (1) cleaving pro-interleukin-1β (pro-IL-1β) and pro-IL-18 to produce active pro-inflammatory cytokines, and (2) cleaving gasdermin D to initiate pyroptotic cell death. In the brain, caspase-1 activation in microglia and neurons contributes to neuroinflammation and neuronal loss in Alzheimer's disease, Parkinson's disease, and other neurodegenerative disorders[@browning2022].

Structure and Activation

Domain Architecture

Caspase-1 contains several structural features[@martin2019]:

Caspase-1 Protein

<div class="infobox infobox-protein">

| Property | Value |
|----------|-------|
| Protein Name | Caspase-1 |
| Gene | CASP1 |
| UniProt ID | P29466 |
| Molecular Weight | ~45 kDa (active enzyme) |
| Subcellular Localization | Cytoplasm, inflammasome complexes |
| Protein Family | Caspase family (inflammatory caspases) |
| Tissue Expression | Primarily immune cells; low in healthy brain |

</div>

Overview

Caspase-1 is an inflammatory caspase encoded by the [CASP1](/genes/casp1) gene that plays central roles in the innate immune response and inflammatory cell death (pyroptosis)[@martin2019]. It is synthesized as an inactive zymogen (pro-caspase-1) that is activated by assembly into inflammasome complexes in response to pathogen-associated molecular patterns (PAMPs) and damage-associated molecular patterns (DAMPs).

Once activated, caspase-1 performs two critical functions: (1) cleaving pro-interleukin-1β (pro-IL-1β) and pro-IL-18 to produce active pro-inflammatory cytokines, and (2) cleaving gasdermin D to initiate pyroptotic cell death. In the brain, caspase-1 activation in microglia and neurons contributes to neuroinflammation and neuronal loss in Alzheimer's disease, Parkinson's disease, and other neurodegenerative disorders[@browning2022].

Structure and Activation

Domain Architecture

Caspase-1 contains several structural features[@martin2019]:

Activation Mechanism

Caspase-1 is activated through a multi-step process:

Inflammasome Complexes

Several inflammasomes activate caspase-1:

| Inflammasome | Sensor | Activator |
|--------------|--------|-----------|
| NLRP3 | NLRP3 | ATP, crystals, aggregates |
| AIM2 | AIM2 | Double-stranded DNA |
| NLRC4 | NLRC4 | Bacterial flagellin |
| NLRP1 | NLRP1 | Toxins, viral proteins |

Normal Biological Function

Inflammatory Cytokine Processing

Caspase-1 processes key inflammatory cytokines:

Pyroptosis Execution

Caspase-1 triggers pyroptotic cell death[@browning2022]:

Host Defense

In the immune system, caspase-1 functions in:

• Defense against bacterial infections
• Clearance of intracellular pathogens
• Antiviral immunity

Role in Neurodegeneration

Alzheimer's Disease

Caspase-1 is a key player in AD neuroinflammation[@schwartz2023]:

Inflammasome Activation:

• NLRP3 inflammasome is activated in AD microglia
• A-beta aggregates trigger NLRP3 activation
• Caspase-1 becomes overactive in AD brains

• IL-1β release amplifies neuroinflammation
• Pyroptotic cell death of neurons and glia
• Chronic inflammation drives progression

• NLRP3 inhibitors reduce pathology in models
• Caspase-1 inhibitors are in development

Parkinson's Disease

Caspase-1 contributes to PD through:

Other Neurodegenerative Conditions

| Disease | Caspase-1 Role |
|---------|---------------|
| ALS | Motor neuron pyroptosis |
| MS | Oligodendrocyte death |
| Huntington's | Mutant huntingtin activates NLRP3 |

Neuroinflammation Cascade

Caspase-1 drives neuroinflammation through:

• Cytokine release (IL-1β, IL-18)
• Immune cell recruitment
• Blood-brain barrier disruption
• Synaptic dysfunction

Therapeutic Implications

Current Approaches

Targeting caspase-1 is actively being explored[@browning2022]:

| Strategy | Approach | Status |
|----------|----------|--------|
| Caspase-1 inhibitors | Small molecules (VX-765, YVAD) | Clinical trials |
| NLRP3 inhibitors | MCC950, Dapansutrile | Clinical trials |
| IL-1R antagonists | Anakinra, Canakinumab | Various stages |
| Anti-inflammatory | Minocycline, Edaravone | Approved/useful |

Challenges

Related Therapies

• [Anakinra](/therapeutics/anakinra) — IL-1 receptor antagonist
• [Canakinumab](/therapeutics/canakinumab) — Anti-IL-1β antibody

Key Publications

Cross-References

• [CASP1 Gene](/genes/casp1) — Gene encoding caspase-1
• [Alzheimer's Disease](/diseases/alzheimers-disease) — Related disease
• [Parkinson's Disease](/diseases/parkinsons-disease) — Related disease
• [Neuroinflammation](/mechanisms/neuroinflammation-mechanisms) — Pathogenic mechanism
• [Pyroptosis](/mechanisms/pyroptosis) — Cell death pathway

See Also

• [Inflammasome](/topics/inflammasome)
• [Interleukin-1](/topics/interleukin-1)
• [Microglial Activation](/topics/microglial-activation)

References